HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rachel Thijssen Selected Research
Rachel Thijssen Research Topics
Disease
8
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2022 - 08/2015
5
Neoplasms (Cancer)
11/2020 - 01/2019
3
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 01/2019
2
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 11/2020
2
Disease Progression
01/2021 - 01/2019
1
Leukemia
01/2021
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1
Hematologic Neoplasms (Hematological Malignancy)
01/2021
1
Thrombocytopenia (Thrombopenia)
01/2021
1
Lymphoma (Lymphomas)
01/2020
1
Lymphadenopathy
01/2016
1
Lymphocytosis
01/2016
Drug/Important Bio-Agent (IBA)
11
venetoclax
IBA
11/2022 - 08/2015
4
Proteins (Proteins, Gene)
FDA Link
11/2022 - 10/2019
2
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 01/2016
2
Pharmaceutical Preparations
IBA
01/2021 - 01/2020
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2022
1
navitoclax
IBA
01/2021
1
ibrutinib
IBA
01/2019
1
Circulating Tumor DNA
IBA
01/2019
1
1- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- one
IBA
01/2016
1
Antibodies
IBA
08/2015
1
Phosphotransferases (Kinase)
IBA
08/2015
Therapy/Procedure
5
Therapeutics
11/2022 - 01/2019